Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
It is hypothesized that a consistent use of the Hemocontrol TM biofeedback function improves long-term cardiovascular outcome, mediated by reduced hypertension due to fluid overload and by reduced incidence of intradialytic hypotensive episodes
Epistemonikos ID: 49e3e5a06d5b67e5c96152972019a0249bf0c73d
First added on: May 10, 2024